WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$152M |
| 3 |
Brown & Brown
BRO
|
$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
$113M |
| 5 |
Akero Therapeutics
AKRO
|
$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
$144M |
| 2 |
MetLife
MET
|
$97.2M |
| 3 |
Travelers Companies
TRV
|
$91.9M |
| 4 |
Electronic Arts
EA
|
$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VOYG
826
Voyager Technologies, Inc.
VOYG
$1.73B
| $785K | ﹤0.01% |
+20,000
| New | +$785K |
|
827
MGM Resorts International
MGM
$9.98B
| $768K | ﹤0.01% |
22,345
+3,444
| +18% | +$118K |
|
828
PepGen
PEPG
$45.9M
| $768K | ﹤0.01% |
691,530
-89,367
| -11% | -$99.2K |
|
829
Invesco
IVZ
$9.81B
| $762K | ﹤0.01% |
48,351
+10,501
| +28% | +$166K |
|
830
Ericsson
ERIC
$26.7B
| $761K | ﹤0.01% |
+89,762
| New | +$761K |
|
831
Fox Class B
FOX
$24.9B
| $737K | ﹤0.01% |
14,271
+3,126
| +28% | +$161K |
|
832
Core Scientific
CORZ
$4.16B
| $710K | ﹤0.01% |
+41,566
| New | +$710K |
|
|
BOW
833
Bowhead Specialty Holdings
BOW
$1.08B
| $706K | ﹤0.01% |
18,820
+4,872
| +35% | +$183K |
|
834
Day One Biopharmaceuticals
DAWN
$773M
| $653K | ﹤0.01% |
100,516
-112,638
| -53% | -$732K |
|
835
Campbell Soup
CPB
$10.1B
| $652K | ﹤0.01% |
21,287
+4,664
| +28% | +$143K |
|
836
Caesars Entertainment
CZR
$5.48B
| $638K | ﹤0.01% |
22,468
+4,516
| +25% | +$128K |
|
837
ATAI Life Sciences
ATAI
$980M
| $637K | ﹤0.01% |
290,943
+8,758
| +3% | +$19.2K |
|
838
Korro Bio
KRRO
$312M
| $626K | ﹤0.01% |
50,094
| – | – |
|
839
Zentalis Pharmaceuticals
ZNTL
$126M
| $615K | ﹤0.01% |
530,582
| – | – |
|
840
Gossamer Bio
GOSS
$668M
| $609K | ﹤0.01% |
495,153
-233,306
| -32% | -$287K |
|
841
Gen Digital
GEN
$18.2B
| $600K | ﹤0.01% |
20,395
-7,195
| -26% | -$212K |
|
842
InflaRx
IFRX
$112M
| $594K | ﹤0.01% |
751,267
+283
| +0% | +$224 |
|
843
PAR Technology
PAR
$1.96B
| $590K | ﹤0.01% |
+8,509
| New | +$590K |
|
844
NETSCOUT
NTCT
$1.79B
| $582K | ﹤0.01% |
+23,460
| New | +$582K |
|
845
IDEX
IEX
$12.4B
| $581K | ﹤0.01% |
+3,311
| New | +$581K |
|
|
ALMS
846
Alumis Inc. Common Stock
ALMS
$469M
| $577K | ﹤0.01% |
+192,490
| New | +$577K |
|
847
Enphase Energy
ENPH
$5.18B
| $562K | ﹤0.01% |
14,175
+2,984
| +27% | +$118K |
|
848
Altimmune
ALT
$334M
| $553K | ﹤0.01% |
+142,863
| New | +$553K |
|
849
WIX.com
WIX
$8.52B
| $551K | ﹤0.01% |
3,480
+1,188
| +52% | +$188K |
|
850
TriNet
TNET
$3.43B
| $547K | ﹤0.01% |
7,475
-56,228
| -88% | -$4.11M |
|